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Introduction
Catheter-related infections are common life-threaten-
ing healthcare-associated infections whose incidence
can be decreased by improving the quality of care.
Optimisation of skin antisepsis is essential to prevent
short-term catheter-related infections. We hypothe-
sised that chlorhexidine-alcohol was more effective
than povidone iodine-alcohol as a skin antiseptic for
preventing infections.
Methods
In our open-label, randomised controlled trial, we
enrolled consecutive adults (≥ 18 years) admitted to one
of 11 French intensive care units and requiring at least
one central-venous, haemodialysis, or arterial catheter.
Before catheter insertion, we randomly assigned patients
by a secure web-based random-number generator
(1:1:1:1, permuted blocks of eight, stratified by centres)
to have all the intravascular catheters prepared with
chlorhexidine-alcohol or povidone iodine-alcohol,
applied in one or two steps (cleaning the skin with anti-
septic detergent prior to antiseptic application). The
incidence of catheter-related infections with chlorhexi-
dine-alcohol versus povidone iodine-alcohol was the pri-
mary outcome. Physicians and nurses were not masked
to group assignment but microbiologists and outcome
assessors were. Analyses were by intention to treat. This
study is registered with ClinicalTrials.gov, number
NCT01629550 and the protocol has been published (see
Goudet et al).
Results
Between Oct 26, 2012, and Feb 12, 2014, 2546 patients
were eligible to participate in the study and 2349
(92.3%) were randomly assigned to chlorhexidine-alco-
hol (1181 patients [2547 catheters]) or povidone
iodine-alcohol (1168 patients [2612 catheters]). Chlor-
hexidine-alcohol was associated with lower incidence
of catheter-related infections (0.28 versus 1.77 per
1000 catheter-days; hazard ratio 0.15, 95% CI 0.05,0.41;
p = 0·0002) compared to povidone iodine-alcohol.
None of the antiseptics caused systemic adverse events.
Chlorhexidine-alcohol was also superior for secondary
end points:(CR-BSI HR = 0.21 (0.07,0.59), p = 0.003
and catheter colonization HR = 0·18 (0.13,0.24), p <
0.0001).
Detersion prior to antisepsis did not influenced the
risk of infection (HR= 1.03 (0.57,1.88), p = 0.91) or
catheter colonization (HR= 1.10 (0.89,1.35), p = 0.39).
Severe skin reactions occurred more frequently with
chlorhexidine-alcohol (27 [2.6%] versus 7 [0.7%] patients;
p = 0.0017), and led to chlorhexidine discontinuation in
two patients.
Conclusions
For skin antisepsis, chlorhexidine-alcohol provides
greater protection against short-term catheter-related
infections than does povidone iodine-alcohol, and it16Paris, Medical and Infectious Diseases ICU, Paris, France
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should be included in all bundles for prevention of
intravascular catheter-related infections.
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